In SLE patients, defective NTPDase1/CD39 expression and impaired Treg functions (Loza et al., 2011) are associated with A2A adenosine receptor upregulation in peripheral lymphocytes. This evidence concerns the gene ADORA2A and systemic lupus erythematosus.